Impact of tobacco on bronchopulmonary affections: magnitude of the problem

##plugins.themes.academic_pro.article.sidebar##

Published Dec 8, 2011
Download
pdf
Vol. 89 No. 11 (2011): Issue Nov 2011

##plugins.themes.academic_pro.article.main##

Leila El Fekih
Anissa Berraies
Agnes Hamzaoui
Soraya Fenniche
Mohamed Lamine Megdiche
Hamouda Boussen

Abstract

Background: Tobacco smoking is frequent in the world affecting 20 à 50% of the population but with a decrease in occidental countries due to a huge effort based on sensiblisation and anti-tobacco decisions.
Aim: To review the impact of tobacco on bronchopulmonary affections.
Methods: A narrative review of literature
Results: In the next future, yearly tobacco-related deaths could increase from 4.2 millions in 2000 to 10 millions in 2025-2030 making smoking as the main evitable cause of deaths by respiratory diseases. Lung cancer is the leading killer cancer. Tobacco is the most frequent cause of respiratory diseases. It is responsible of 80 to 90% of deaths by chronic obstructive pneumobronchopathiy (COPD) and 80 to 85% deaths by bronchopulmonary cancer.
Conclusion: Tobacco is a « chronic disease » necessitating management with advices and medical treatment.

Keywords:

Tobacco, diseases, bronchopneumopathies, tuberculosis, lung cancer, prevention, legislation

##plugins.themes.academic_pro.article.details##

References

  1. 1/DGS/GTNDO «Broncho Pneumopathie Chronique obstructive» http://www.sante.gouv.fr/htm/dossiers/losp/50bpco.pdf
  2. Cancer in the European Union in 1990 EUCAN90 Version1.1 IARC 1996. Lyon: International Agency for Research on Cancer, 1997.
  3. Le manifeste des patients atteints de BPCO. Rev Mal Respir 2003; 20: 471-476
  4. Huchon G., Vergnenegre A., Neukirch F., Brami G., Roche N., Preux P.M. Chronic bronchitis among french adults: high prevalence and underdiagnosis. Eur Respir J 2001; 20: 806-812
  5. Cerveri I, Accordini S, Verlato G et al. For the ERCHS study group Variation in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 2001; 18: 85-92
  6. Fuhrman C, Jougla E, Nicolau J, Eilstein D, Delmas MC. Chronic obstructive pulmonary disease deaths in France: a multiple-cause analysis Thorax 2006; 61: 930-34.
  7. Murray CJ, Lopez AD. Evidence-based health policy--lessons from the Global Burden of Disease Study. Science 1996; 274:740-3
  8. Maalej M, Bouacha H, Ben Miled T et al. La bronchite chronique en Tunisie: aspect épidémiologique. Tunis Méd. 1986; 64: 457-60.
  9. Fakhfakh R, Hsairi M, Ben Romdhane H, Achour N. Mortalité attribuable au tabac en Tunisie en 1997. Tunis Med 2001; 79: 408-12.
  10. Rapport 2009 sur la lutte contre la tuberculose dans le monde http://www.who.int/tb/publications/global_report/2009/key_points/ fr/
  11. Bulletin National épidémiologique du Ministère de la santé publique. 2007; 1: 7.
  12. Ariyothai N; Podhipak A; Akarasewi P; Tornee S; Smithtikarn S; Thongprathum P. Cigarette smoking and its relation to pulmonary tuberculosis in adults. South Asian J Trop Med Publ Health 2004; 35: 219-27.
  13. Bothamley GH. Smoking and tuberculosis: a chance or causal association? Possible explanations for the association between smoking and tuberculosis. Thorax 2005; 60: 527-28.
  14. Den Boon S, Van Lill SWP, Borgdorff MW et al. The association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax 2005; 60: 555-57.
  15. Slama K, Chiang C-Y, Enarson D et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis.2007; 11:1049-61.
  16. Abal AT, Jayakrishnana B, Parwer S et al. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respir Med 2005; 99:415-20.
  17. Racil H, Ben Amar J, Cheikrouhou S et al. Particularités de la tuberculose pulmonaire chez le tabagique. Presse Med 2010; 39:e25-e28.
  18. Fekih L, Boussoffara L, Abdelghaffar H et al. Effect of tobacco pulmonary tuberculosis.Rev Med Liege. 2010; 65: 152-5.
  19. L.Thiberville, C Paris. Encyclopédie Médico-Chirurgicale 6-002- G-05 (2004)
  20. Vineis P, Alavanja M, Buffler P et al. Tobacco and Cancer: Recent Epidemiological Evidence. J Nat Cancer Instit 2004; 96:
  21. Doll R, Hill AB. A study of aetiology of carcinoma of the lung. BMJ 1952; 225(ii): 1271-86.
  22. Tyczynski JE, Bray F, Parkin DM. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol. 2003; 4:45-55.
  23. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003; 123:21S-49S
  24. Gu D, Kelly TN, Wu X, et al. Mortality attributable to smoking in China. N Engl J Med 2009; 360: 150-159.
  25. Registre des cancers Nord Tunisie. Données 1999-2003, Evolution 1994-2003, Projections à l'horizon 2024.
  26. Blanchon F, Grivaux M, Collon T et al. Épidémiologie du cancer bronchique primitif pris en charge dans les centres hospitaliers généraux français. Étude KBP 2000 CHPG du Collège des Pneumologues des Hôpitaux Généraux Français. Rev Mal Respir 2002; 19: 727-34.
  27. Simonato L, Agudo A, Ahrens W et al. Lung cancer and cigarette smoking in Europe : an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 2001; 91:876-87.
  28. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking : 40 years'observation on male British doctors. Br Med J 1994; 309: 901-11.
  29. B'chir F, Laouani A, Ksibi S, Arnaud MJ, Saguem S. Cigarette filter and the incidence of lung adenocarcinoma among Tunisian population. Lung Cancer 2007; 57: 26-33.
  30. El Mezni F, Mrabet N, Ismail O et al. Profil anatomopathologique des cancers broncho pulmonaires. Tun Med. 2005; 83: 157-62.
  31. Trédaniel J, Savinelli F, Vignot S, Bousquet G, Lemaignan C, Misset JL. Conséquences du tabagisme passif chez l'adulte. Rev Mal Respir 2006 ; 23 :S00-3S00
  32. US Environmental Protection Agency : Respiratory health effects of passive smoking: lung cancer and other disorders. NIH Publication N° 93-3605 1993 ; Monograph 4.26/John MR, Sung HY, Max W. Economic cost of tobacco use in India, 2004. Tob Control. 2009; 18: 138-43.
  33. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. Br Med J 1997; 315: 980-88.
  34. Tockman MS, Anthonisen NR, Wright EC. Airways obstruction and the risk for lung cancer.Ann Intern Med1987; 106: 512-18.
  35. Nomura A, Stemmermann GN, Chyou PH, Marcus EB, Buist AS. Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis 1991; 144: 307-11.
  36. Sung H-Y, Wang L, Jin S, et al. Economic burden of smoking in China, 2000. Tob Control 2006; 15: 5-11.
  37. John MR, Sung HY, Max W. Economic cost of tobacco use in India, 2004. Tob Control. 2009;18: 138-43.
  38. Zaher C, Halbert R, Dubois R, George D, Nonikov D. Smokingrelated diseases: the importance of COPD. Int J Tubercul Lung Dis. 2004; 8:1423-28.
  39. McGhee SM, Ho LM, Lapsley HM et al. Cost of tobacco-related diseases, including passive smoking, in Hong Kong. Tob Control 2006; 15: 125-130
  40. Reynales-Shigematsu LM, Rodríguez-Bolaños Rde L, Jiménez JA, Juárez-Márquez SA, Castro-Ríos A, Hernández-Avila M. [Health care costs attributable to tobacco consumption on a national level in the Mexican Social Security Institute]. Salud Publica Mex. 2006;48 Suppl 1:S48-64.
  41. Leartsakulpanitch J, Nganthavee W, Salole E. The Economic Burden of Smoking-Related Disease in Thailand: A Prevalence- Based Analysis. J Med Assoc Thai 2007; 90: 1925-9.